Danone ADR (DANOY)

$DANOY Danone to acquire majority stake in Kate Farms Danone announced that it has entered into a definitive agreement to acquire a majority stake in Kate Farms, a U.S. business offering a wide array of plant-based, organic nutrition products for both medical and everyday needs. Kate Farms' complementary products will enhance Danone's specialized nutrition offerings, Danone said in a statement. Following the closing of the transaction, Kate Farms' CEO, Brett Matthews, will serve as Chairman and CEO of Danone's North American Medical Nutrition business. Kate Farms' senior management will retain a minority stake in the combined business. The transaction remains subject to customary closing conditions, including regulatory approval.

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Danone PK. Is that bullish or bearish? $DANOY #RsiOverbought #OTCQX

$DANOY silent killer here :)

$DANOY earnings drop incoming 👀 Street's buzzing about this under-the-radar retail play. Will numbers match the whispers? Time to stalk those financials – could be a sneaky volatility window. Coffee-charting mode activated ☕ (No position, just watching heat)

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Danone PK. Is that bullish or bearish? $DANOY #RsiOverbought #OTCQX

$ETH.X $HOOD $DANOY HUNTING

$OTLY Yesterday I was visiting a friend who made me a cappuccino of the $DANOY Alpro branded barista oat milk. I can honestly say: it was disgusting, it tastes totally different than the Oatly barista version, in a bad way. It tastes more like real milk. In order to be not biased I also tasted the pure Alpro oat milk. Well my verdict hasn't changed. I suggested him to try Oatly :P

$LWAY $DANOY Lifeway Foods confirms $27.00 per share buyout proposal from Danone Lifeway Foods (LWAY) confirmed that it has received a revised, unsolicited, non-binding proposal from Danone North America (DANOY) to acquire all outstanding shares of common stock of Lifeway it does not already own for $27.00 per share in cash. According to the Schedule 13D amendment filed with the U.S. SEC disclosing the revised proposal, Danone beneficially owns approximately 23.3% of Lifeway's outstanding common stock. On November 5, Lifeway announced that its Board of Directors had rejected Danone's initial unsolicited, non-binding proposal to acquire all the shares of Lifeway that it does not already own for $25.00 per share because the Board determined that the initial proposal substantially undervalued Lifeway and was not in the best interests of the company and its shareholders and other stakeholders. Consistent with its fiduciary duties, Lifeway's board of directors, in consultation with its independent outside advisors, will carefully review and evaluate the revised proposal to determine the course of action that it believes is in the best interests of the company and its shareholders and other stakeholders.

$DANOY Danone price target raised to EUR 66 from EUR 63 at Jefferies Jefferies analyst David Hayes raised the firm's price target on Danone to EUR 66 from EUR 63 and keeps a Hold rating on the shares. The firm believes there was enough in last week's Q3 results to keep faith in FY24 delivery. Key growth areas continued to perform, led by U.S. EDP and China SN. But Jefferies sees specific challenges for the growth sustainability into 2025 for U.S. Creamers and China infant formula. The Europe miss in Q3, and associated negative pricing, could also indicate the need for heightened investment, the firm adds, noting that hopes of midterm accelerated sales, or year-over-year margin progression may need to be contained.

$LWAY $DANOY Lifeway Foods confirms $25.00 per share buyout proposal from Danone Lifeway Foods (LWAY) confirmed that it has received an unsolicited, non-binding proposal from Danone North America PBC (DANOY) to acquire all outstanding shares of common stock of Lifeway it does not already own for $25.00 per share in cash. According to the Schedule 13D amendment filed yesterday with the U.S. Securities and Exchange Commission disclosing the proposal, Danone beneficially owns approximately 23.4% of Lifeway's outstanding common stock. Consistent with its fiduciary duties, Lifeway's board of directors, in consultation with its independent outside advisors, will carefully review and evaluate the proposal to determine the course of action that it believes is in the best interests of the Company and its stakeholders.

$DANOY Danone confirms 2024 guidance 2024 guidance confirmed: Like-for-like sales growth between +3% and +5% with moderate improvement in recurring operating margin.

$DANOY Danone reports 1H revenue EUR 13.76B vs. EUR 14.17B last year Reports recurring EPS EUR 1.80 vs. EUR 1.76 last year. In H1 2024, consolidated sales stood at EUR 13.757B, up +4.0% on a like-for-like basis, with a balanced contribution from volume/mix and price. On a reported basis, sales decreased by -2.9%, reflecting notably a negative impact from scope and forex, and a positive contribution of hyperinflation. "We have delivered a strong performance for the first half of the year, demonstrating consistency in delivering quality growth: net sales increased by +4.0% on a like-for-like basis, driven by volume/mix up +2.1%, with all categories contributing. We keep driving our category growth, further fueling our winning platforms High Protein, Medical Nutrition, Coffee Creations and Away-from-home. We also remain focused on driving our core portfolio, as reflected by the progressive strengthening of our competitiveness across categories. We continue rebuilding our fundamentals, doubling down on Renew Danone, and have established solid foundations for the "next chapter" of our consumer centric and science-based strategy," CEO Antoine de Saint-Affrique said.

$DANOY Danone price target lowered to EUR 65 from EUR 66 at Morgan Stanley Morgan Stanley lowered the firm's price target on Danone to EUR 65 from EUR 66 and keeps an Overweight rating on the shares. While the firm continues to believe that Danone's portfolio offers higher growth than consensus assumes, it also sees pricing moderating faster than previously anticipated and assumes this low pricing is maintained in the future, so it is updating estimates to reflect this.

$DANOY Danone confirms 2024 guidance Sees like-for-like sales growth expected between +3% and +5%, with moderate improvement in recurring operating margin.

$DANOY Danone reports Q1 revenue EUR 6.79B vs. EUR 6.96B last year In Q1 2024, consolidated sales stood at EUR 6.8B, up +4.1% on a like-for-like basis, led by an increase of +1.2% from volume/mix and +2.9% from price. On a reported basis, sales decreased by -2.5%, mainly penalized by the strong negative impact from scope, resulting from the deconsolidation of EDP Russia starting from July 2023, and the negative impact from forex of -3.2%. Besides, hyperinflation contributed positively to reported sales. CEO Antoine de Saint-Affrique commented, "We have delivered a good start to the year, with yet another quarter of quality growth and consistent delivery on our Renew Danone agenda: net sales were up +4.1% on a like-for-like basis and volume/mix up +1.2%, with all categories positively contributing. In what remains a challenging environment, we continued making good progress on our transformation agenda, strengthening our category fundamentals, intentionally driving our winning mixes and geographies while delivering on portfolio rotation with the successful closing of the disposals of our milk and dairy activity Horizon Organic and Wallaby in the US and Michel & Augustin. We are confident that 2024 will be another year where we deliver on our value creation model. With that in mind, we look forward to talking more about the next chapter of Renew Danone at our Capital Market Event in Amsterdam in June."

Current Analysis: Danone $DANOY https://talkmarkets.com/content/stocks--equities/current-analysis-danone-danoy?post=440996

$BETSF I don't know what's up with all the doom and gloom as I am actually up 17.25% at the moment. With the evidence #ShareIntel has collected I cannot see NASDAQ delisting. Even if I am wrong, BETS would be in good company on the OTCQB with the likes of $RHHBY, $DANOY, $BASFY and $REPYY to name just a few. The upcoming week should be interesting.

$DANOY Danone plans to sell Russian operations to Chechnya-linked businessman, FT says Danone plans to sell its rebranded Russian business Life & Nutrition to Vamin Tatarstan, a Russian dairy company owned by Mintimer Mingazov, a nephew of Chechen strongman Ramzan Kadyrov, The Financial Times' Courtney Weaver and Adrienne Klasa report, citing documents and people familiar with the situation. The move comes seven months after Vladimir Putin ordered seizure of French food group's local operations.

$DANOY Danone sees FY24 guidance in line with mid-term ambitions Danone says like-for-like sales growth is expected between +3% and +5%, with a moderate improvement in recurring operating margin.

$DANOY Danone reports FY23 recurring EPS EUR 3.54 vs. EUR 3.43 last yea Reports FY23 revenue EUR 27.62B vs. EUR 26.66B last year. CEO Antoine de Saint-Affrique said: "2023 was a year of consistent progress and strong delivery against our Renew Danone agenda. We put science back at the heart of what we do and further tied sustainability to business performance. We made significant progress in sharpening our portfolio. We further invested behind our brands, our innovations and our capabilities, progressively improving the quality of our growth, while creating value for all stakeholders. In a context which remains challenging, the progressive improvement of our volume-mix, turning positive in Q4, the visible progress made by EDP Europe, and the continued strong momentum of our Medical Nutrition activity are encouraging signs, even if lots remains to be done. Building on the positive momentum of 2023, we are starting this new financial year with confidence in our Renew strategy....

$DANOY Danone upgraded to Buy from Sell at UBS UBS upgraded Danone to Buy from Sell with a price target of EUR 70, up from EUR 47.50. The analyst says benefits from the company's portfolio transformation and marked reinvestments will become visible in 2024, driving earnings upgrades and re-rating of the shares.

$DANOY Danone: Information on the total number of voting rights and shares